Orexo sues Sun Pharma over opioid dependence generic
16-09-2020
US judge dismisses attorney’s ‘opportunistic’ whistleblower suit
14-05-2020
Pavel Kapysh / Shutterstock.com
Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bausch Health, Sun Pharma, generics, generic litigation, Xifaxan, antibiotics, ANDA, FDA, settlement
